ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 61 filers reported holding ALIGOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,775 | -23.1% | 97,423 | 0.0% | 0.00% | – |
| Q2 2023 | $94,598 | +11.1% | 97,423 | 0.0% | 0.00% | – |
| Q1 2023 | $85,148 | -26.5% | 97,423 | -19.9% | 0.00% | – |
| Q4 2022 | $115,916 | +73.0% | 121,646 | +100.0% | 0.00% | – |
| Q3 2022 | $67,000 | -9.5% | 60,823 | 0.0% | 0.00% | – |
| Q2 2022 | $74,000 | -91.5% | 60,823 | -85.0% | 0.00% | – |
| Q1 2022 | $870,000 | -81.2% | 404,756 | +3.8% | 0.00% | – |
| Q4 2021 | $4,630,000 | -20.2% | 390,037 | +4.2% | 0.00% | – |
| Q3 2021 | $5,804,000 | -4.6% | 374,232 | +25.3% | 0.00% | – |
| Q2 2021 | $6,087,000 | +55.5% | 298,587 | +73.5% | 0.00% | – |
| Q1 2021 | $3,914,000 | -11.5% | 172,140 | +7.6% | 0.00% | – |
| Q4 2020 | $4,422,000 | – | 159,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |